Adiponectin also plays a role in the suppression of metabolic disorders that may cause obesity, nonalcoholic fatty liver disease (NAFLD), or type-2 diabetes mellitus (T2DM) [87, 90, 91]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.